HHS Secretary Xavier Becerra has signed off on a reorganization of HRSA that elevates decision making about the 340B program closer to the top of the department.

Breaking News

News Alert: Becerra Signs off on HRSA Reorganization that Elevates 340B Program’s Status

The 340B drug pricing program has a new, higher profile home within the U.S. Health Resources and Services Administration (HRSA), and likely is getting a new director due to its current director’s promotion. U.S. Health and Human Services (HHS) Secretary Xavier Becerra late yesterday afternoon announced the Biden administration’s revisions to changes the Trump administration made to HRSA in January during its last days in power. The prior administration’s changes have been on hold since they were announced. In late July, HRSA said the reorganization remained under review.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

*Sign up for news summaries and alerts from 340B Report